Murine granulocytes control human tumor growth in SCID mice
β Scribed by Francesco Lozupone; Francesca Luciani; Massimo Venditti; Licia Rivoltini; Serenella Pupa; Giorgio Parmiani; Filippo Belardelli; Stefano Fais
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 430 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A human Burkitt lymphoma (Daudi) has been grown in the mutant mouse called C.Bβ17 SCID. Twentyβeight days after s.c. injection of Daudi cells, a palpable tumor grew only at the site of injection in all injected mice. In contrast, after intravenous (i.v.) or intraperitoneal (i.p.) inject
## Abstract Malignant cells possess a high degree of proteolytic activity in which the plasminogen activator system plays an important role. An increased expression of urokinase type plasminogen activator (uPA) is of significance for degradation of the extracellular tumor matrix, facilitating invas
The effect of weekly y-globulin injection on the development of human B-cell tumors was studied in I20 mice with severe combined immunodeficiency (SCID). The mice were injected intraperitoneally (Lp.) with human peripheral mononuclear cells (PBMC) from 6 different Epstein-Barr virus (EBV)seropositiv